OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatable Traits in Airway Disease: From Theory to Practice
Àlvar Agustí, Peter G. Gibson, Vanessa M. McDonald
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 3, pp. 713-723
Open Access | Times Cited: 44
Àlvar Agustí, Peter G. Gibson, Vanessa M. McDonald
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 3, pp. 713-723
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
COPD and multimorbidity: recognising and addressing a syndemic occurrence
Leonardo M. Fabbri, Bartolomé R. Celli, Àlvar Agustí, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 11, pp. 1020-1034
Open Access | Times Cited: 87
Leonardo M. Fabbri, Bartolomé R. Celli, Àlvar Agustí, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 11, pp. 1020-1034
Open Access | Times Cited: 87
Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
Vanessa M. McDonald, Yuto Hamada, Àlvar Agustí, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 824-837
Closed Access | Times Cited: 13
Vanessa M. McDonald, Yuto Hamada, Àlvar Agustí, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 824-837
Closed Access | Times Cited: 13
From treatable traits to GETomics in airway disease: moving towards clinical practice
Alberto Papi, Rosa Faner, Ian Pavord, et al.
European Respiratory Review (2024) Vol. 33, Iss. 171, pp. 230143-230143
Open Access | Times Cited: 9
Alberto Papi, Rosa Faner, Ian Pavord, et al.
European Respiratory Review (2024) Vol. 33, Iss. 171, pp. 230143-230143
Open Access | Times Cited: 9
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Alberto Papi, Franco Alfano, Tommaso Bigoni, et al.
Archivos de Bronconeumología (2024) Vol. 60, Iss. 5, pp. 269-278
Open Access | Times Cited: 8
Alberto Papi, Franco Alfano, Tommaso Bigoni, et al.
Archivos de Bronconeumología (2024) Vol. 60, Iss. 5, pp. 269-278
Open Access | Times Cited: 8
Treatable traits for long COVID
Hayley Lewthwaite, Anthony Byrne, Bruce J. Brew, et al.
Respirology (2023) Vol. 28, Iss. 11, pp. 1005-1022
Open Access | Times Cited: 17
Hayley Lewthwaite, Anthony Byrne, Bruce J. Brew, et al.
Respirology (2023) Vol. 28, Iss. 11, pp. 1005-1022
Open Access | Times Cited: 17
Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?
Mario Cazzola, Clive P. Page, Maria Gabriella Matera, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 2, pp. 2300700-2300700
Closed Access | Times Cited: 16
Mario Cazzola, Clive P. Page, Maria Gabriella Matera, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 2, pp. 2300700-2300700
Closed Access | Times Cited: 16
Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease
Shyamali C. Dharmage, Rosa Faner, Àlvar Agustí
Respirology (2024) Vol. 29, Iss. 7, pp. 551-562
Open Access | Times Cited: 5
Shyamali C. Dharmage, Rosa Faner, Àlvar Agustí
Respirology (2024) Vol. 29, Iss. 7, pp. 551-562
Open Access | Times Cited: 5
Investigational anti IL-13 asthma treatments: a 2023 update
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 5, pp. 373-386
Closed Access | Times Cited: 12
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 5, pp. 373-386
Closed Access | Times Cited: 12
Treatable traits models of care
Vanessa M. McDonald, Anne E. Holland
Respirology (2023) Vol. 29, Iss. 1, pp. 24-35
Open Access | Times Cited: 12
Vanessa M. McDonald, Anne E. Holland
Respirology (2023) Vol. 29, Iss. 1, pp. 24-35
Open Access | Times Cited: 12
Pulmonary function tests: an integrated approach to interpreting results in the search for treatable traits
Agnaldo José Lopes
Expert Review of Respiratory Medicine (2025)
Closed Access
Agnaldo José Lopes
Expert Review of Respiratory Medicine (2025)
Closed Access
Expert opinion on gray areas in asthma management: A lesson from the innovative project “revolution in asthma” of the Italian thoracic society (AIPO‐ITS)
Adriano Vaghi, Raffaele Antonelli Incalzi, Simona Barbaglia, et al.
Clinical and Translational Allergy (2025) Vol. 15, Iss. 2
Open Access
Adriano Vaghi, Raffaele Antonelli Incalzi, Simona Barbaglia, et al.
Clinical and Translational Allergy (2025) Vol. 15, Iss. 2
Open Access
Asthma Phenotypes and Biomarkers
Jocelyn R. Grunwell, Anne M. Fitzpatrick
Respiratory Care (2025)
Closed Access
Jocelyn R. Grunwell, Anne M. Fitzpatrick
Respiratory Care (2025)
Closed Access
Asthma treatable traits: How far do we have to go?
Honglei Shi, Kewu Huang
Chinese Medical Journal (2025)
Open Access
Honglei Shi, Kewu Huang
Chinese Medical Journal (2025)
Open Access
Practical Guidelines for Asthma Management (PGAM): Digest edition
Jun Tamaoki, Hiroyuki Nagase, Hiroyuki Sano, et al.
Respiratory Investigation (2025) Vol. 63, Iss. 3, pp. 405-421
Closed Access
Jun Tamaoki, Hiroyuki Nagase, Hiroyuki Sano, et al.
Respiratory Investigation (2025) Vol. 63, Iss. 3, pp. 405-421
Closed Access
An update on long-acting muscarinic agents for asthma therapy
Maria Gabriella Matera, Mario Cazzola, Paola Rogliani, et al.
Expert Review of Respiratory Medicine (2025)
Closed Access
Maria Gabriella Matera, Mario Cazzola, Paola Rogliani, et al.
Expert Review of Respiratory Medicine (2025)
Closed Access
Treatable traits, combination inhaler therapy and the future of asthma management
Peter G. Gibson, Vanessa M. McDonald, Dennis Thomas
Respirology (2023) Vol. 28, Iss. 9, pp. 828-840
Open Access | Times Cited: 10
Peter G. Gibson, Vanessa M. McDonald, Dennis Thomas
Respirology (2023) Vol. 28, Iss. 9, pp. 828-840
Open Access | Times Cited: 10
Towards personalized medicine for the treatment of equine asthma
L. Leduc, Mathilde Leclère, Jean‐Pierre Lavoie
The Veterinary Journal (2024) Vol. 305, pp. 106125-106125
Open Access | Times Cited: 3
L. Leduc, Mathilde Leclère, Jean‐Pierre Lavoie
The Veterinary Journal (2024) Vol. 305, pp. 106125-106125
Open Access | Times Cited: 3
Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1–3 treatment: A nationwide asthma cohort study
Jon R. Konradsen, Stina Selberg, Maria Ödling, et al.
Respirology (2024)
Open Access | Times Cited: 3
Jon R. Konradsen, Stina Selberg, Maria Ödling, et al.
Respirology (2024)
Open Access | Times Cited: 3
The Precision Medicine Era of Bronchiectasis
Sanjay H. Chotirmall, James D. Chalmers
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 1, pp. 24-34
Open Access | Times Cited: 3
Sanjay H. Chotirmall, James D. Chalmers
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 1, pp. 24-34
Open Access | Times Cited: 3
Change is in the air: key questions on the ‘Treatable Traits’ model for chronic airway diseases in primary care
Àlvar Agustí, Peter G. Gibson, Liam G. Heaney, et al.
npj Primary Care Respiratory Medicine (2024) Vol. 34, Iss. 1
Open Access | Times Cited: 3
Àlvar Agustí, Peter G. Gibson, Liam G. Heaney, et al.
npj Primary Care Respiratory Medicine (2024) Vol. 34, Iss. 1
Open Access | Times Cited: 3
Managing Asthma During Pregnancy and the Postpartum Period
Vanessa E. Murphy, Peter G. Gibson, Michael Schatz
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 12, pp. 3585-3594
Closed Access | Times Cited: 8
Vanessa E. Murphy, Peter G. Gibson, Michael Schatz
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 12, pp. 3585-3594
Closed Access | Times Cited: 8
Gold 2023: Highlights for primary care
Àlvar Agustí, Antoni Sisó‐Almirall, Miguel Román, et al.
npj Primary Care Respiratory Medicine (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 8
Àlvar Agustí, Antoni Sisó‐Almirall, Miguel Román, et al.
npj Primary Care Respiratory Medicine (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 8
Unravelling the complex interplay of factors behind exercise limitations and physical inactivity in COPD
Clarice Tang, Bruce Bernstein, Felicity Blackstock, et al.
Breathe (2024) Vol. 20, Iss. 2, pp. 230180-230180
Open Access | Times Cited: 2
Clarice Tang, Bruce Bernstein, Felicity Blackstock, et al.
Breathe (2024) Vol. 20, Iss. 2, pp. 230180-230180
Open Access | Times Cited: 2
An overview of the preclinical discovery and development of tezepelumab for the treatment of asthma
Maria Gabriella Matera, Josuel Ora, Paola Rogliani, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 9, pp. 951-963
Closed Access | Times Cited: 5
Maria Gabriella Matera, Josuel Ora, Paola Rogliani, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 9, pp. 951-963
Closed Access | Times Cited: 5
Real-World Effectiveness of Statin Therapy in Adult Asthma
ChulHyoung Park, Jae-Hyuk Jang, Chungsoo Kim, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 2, pp. 399-408.e6
Closed Access | Times Cited: 5
ChulHyoung Park, Jae-Hyuk Jang, Chungsoo Kim, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 2, pp. 399-408.e6
Closed Access | Times Cited: 5
